Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Gavaldà J[au]:

Search results

Items: 1 to 50 of 135

1.

Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus.

Len O, Los-Arcos I, Aguado JM, Blanes M, Bodro M, Carratalà J, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Gavaldà J, López-Medrano F, López-Vélez R, Lumbreras C, Mahillo B, Marcos MÁ, Martin-Dávila P, Montejo JM, Moreno A, Muñoz P, Norman F, Pérez-Sáenz JL, Pumarola T, Sabé N, San-Juan R, Vidal E, Domínguez-Gil B; Grupo de Estudio de la Infección en el Trasplante (GESITRA) of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) and the Organización Nacional de Trasplantes (ONT).

Transplant Rev (Orlando). 2020 Apr;34(2):100528. doi: 10.1016/j.trre.2020.100528. Epub 2020 Jan 13. Review.

PMID:
32001103
2.

Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases.

Len O, Los-Arcos I, Aguado JM, Blanes M, Bodro M, Carratalà J, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Gavaldà J, López-Medrano F, López-Vélez R, Lumbreras C, Mahillo B, Marcos MÁ, Martin-Dávila P, Montejo JM, Moreno A, Muñoz P, Norman F, Pérez-Sáenz JL, Pumarola T, Sabé N, San-Juan R, Vidal E, Domínguez-Gil B; Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), and the National Transplant Organization (ONT).

Enferm Infecc Microbiol Clin. 2019 Dec 21. pii: S0213-005X(19)30316-7. doi: 10.1016/j.eimc.2019.10.016. [Epub ahead of print] English, Spanish.

PMID:
31870646
3.

Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance.

Bunsow E, Los-Arcos I, Martin-Gómez MT, Bello I, Pont T, Berastegui C, Ferrer R, Nuvials X, Deu M, Peghin M, González-López JJ, Lung M, Román A, Gavaldà J, Len O.

J Infect. 2020 Feb;80(2):190-196. doi: 10.1016/j.jinf.2019.12.006. Epub 2019 Dec 13.

PMID:
31843689
4.

Association between biomass formation and the prognosis of infective endocarditis due to Staphylococcus aureus.

Fernández-Hidalgo N, Basas J, Viedma E, Ribera A, Larrosa N, Pérez-Montarelo D, Chaves F, Gavaldà J, Almirante B.

Enferm Infecc Microbiol Clin. 2019 Dec 2. pii: S0213-005X(19)30298-8. doi: 10.1016/j.eimc.2019.10.008. [Epub ahead of print] English, Spanish.

PMID:
31806416
5.

European Space Agency experiments on thermodiffusion of fluid mixtures in space.

Braibanti M, Artola P-, Baaske P, Bataller H, Bazile J-, Bou-Ali MM, Cannell DS, Carpineti M, Cerbino R, Croccolo F, Diaz J, Donev A, Errarte A, Ezquerro JM, Frutos-Pastor A, Galand Q, Galliero G, Gaponenko Y, García-Fernández L, Gavaldá J, Giavazzi F, Giglio M, Giraudet C, Hoang H, Kufner E, Köhler W, Lapeira E, Laverón-Simavilla A, Legros J-, Lizarraga I, Lyubimova T, Mazzoni S, Melville N, Mialdun A, Minster O, Montel F, Molster FJ, Ortiz de Zárate JM, Rodríguez J, Rousseau B, Ruiz X, Ryzhkov II, Schraml M, Shevtsova V, Takacs CJ, Triller T, Van Vaerenbergh S, Vailati A, Verga A, Vermorel R, Vesovic V, Yasnou V, Xu S, Zapf D, Zhang K.

Eur Phys J E Soft Matter. 2019 Jul 11;42(7):86. doi: 10.1140/epje/i2019-11849-0. Review.

6.

Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature.

Los-Arcos I, Royuela M, Martín-Gómez MT, Alastruey-Izquierdo A, Sellarès J, Perelló M, Castells L, Dopazo C, Gavaldà J, Len O.

Transpl Infect Dis. 2019 Jun;21(3):e13072. doi: 10.1111/tid.13072. Epub 2019 Mar 27. Review.

PMID:
30865352
7.

Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration.

Pastor M, Basas J, Vairo C, Gainza G, Moreno-Sastre M, Gomis X, Fleischer A, Palomino E, Bachiller D, Gutiérrez FB, Aguirre JJ, Esquisabel A, Igartua M, Gainza E, Hernandez RM, Gavaldà J, Pedraz JL.

Nanomedicine. 2019 Jun;18:101-111. doi: 10.1016/j.nano.2019.02.014. Epub 2019 Mar 6.

PMID:
30849549
8.

Sterilization Procedure for Temperature-Sensitive Hydrogels Loaded with Silver Nanoparticles for Clinical Applications.

Rafael D, Andrade F, Martinez-Trucharte F, Basas J, Seras-Franzoso J, Palau M, Gomis X, Pérez-Burgos M, Blanco A, López-Fernández A, Vélez R, Abasolo I, Aguirre M, Gavaldà J, Schwartz S Jr.

Nanomaterials (Basel). 2019 Mar 6;9(3). pii: E380. doi: 10.3390/nano9030380.

9.

Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.

Basas J, Palau M, Gomis X, Almirante B, Gavaldà J.

PLoS One. 2019 Feb 19;14(2):e0212426. doi: 10.1371/journal.pone.0212426. eCollection 2019.

10.

Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam.

Los-Arcos I, Len O, Martín-Gómez MT, González-López JJ, Saéz-Giménez B, Deu M, Nuvials X, Ferrer R, Román A, Gavaldà J.

Infection. 2019 Apr;47(2):289-292. doi: 10.1007/s15010-018-1261-y. Epub 2018 Dec 19.

PMID:
30565008
11.

Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction.

Peghin M, Los-Arcos I, Hirsch HH, Codina G, Monforte V, Bravo C, Berastegui C, Jauregui A, Romero L, Cabral E, Ferrer R, Sacanell J, Román A, Len O, Gavaldà J.

Clin Infect Dis. 2019 Sep 13;69(7):1192-1197. doi: 10.1093/cid/ciy1047.

PMID:
30561555
12.

Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.

Los-Arcos I, Len O, Perello M, Torres IB, Codina G, Esperalba J, Sellarés J, Moreso F, Seron D, Gavaldà J.

J Clin Virol. 2019 Jan;110:45-50. doi: 10.1016/j.jcv.2018.11.010. Epub 2018 Dec 1.

PMID:
30537648
13.

Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI.

Garcia-Vidal C, Alastruey-Izquierdo A, Aguilar-Guisado M, Carratalà J, Castro C, Fernández-Ruiz M, Aguado JM, Fernández JM, Fortún J, Garnacho-Montero J, Gavaldà J, Gudiol C, Guinea J, Gómez-López A, Muñoz P, Pemán J, Rovira M, Ruiz-Camps I, Cuenca-Estrella M.

Enferm Infecc Microbiol Clin. 2019 Oct;37(8):535-541. doi: 10.1016/j.eimc.2018.03.018. Epub 2018 Jun 28. English, Spanish.

PMID:
29960829
14.

Clinical Characteristics and Outcome of Lung Transplant Recipients with Respiratory Isolation of Corynebacterium spp.

Los-Arcos I, Len O, Martín-Gómez MT, Baroja A, Berastegui C, Deu M, Sacanell J, Román A, Gavaldà J.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00142-18. doi: 10.1128/JCM.00142-18. Print 2018 Aug.

15.

Sub-inhibitory concentrations of oxacillin modify the expression of agr locus in Staphylococcus aureus clinical strains belonging to different clonal complexes.

Viedma E, Pérez-Montarelo D, Villa J, Muñoz-Gallego I, Larrosa N, Fernández-Hidalgo N, Gavaldà J, Almirante B, Chaves F.

BMC Infect Dis. 2018 Apr 16;18(1):177. doi: 10.1186/s12879-018-3088-7.

16.

A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients.

Kumar D, Ferreira VH, Blumberg E, Silveira F, Cordero E, Perez-Romero P, Aydillo T, Danziger-Isakov L, Limaye AP, Carratala J, Munoz P, Montejo M, Lopez-Medrano F, Farinas MC, Gavalda J, Moreno A, Levi M, Fortun J, Torre-Cisneros J, Englund JA, Natori Y, Husain S, Reid G, Sharma TS, Humar A.

Clin Infect Dis. 2018 Oct 15;67(9):1322-1329. doi: 10.1093/cid/ciy294.

PMID:
29635437
17.

Prevalence of Chagas Disease among Solid Organ-Transplanted Patients in a Nonendemic Country.

Salvador F, Sánchez-Montalvá A, Sulleiro E, Moreso F, Berastegui C, Caralt M, Pinazo MJ, Moure Z, Los-Arcos I, Len O, Gavaldà J, Molina I.

Am J Trop Med Hyg. 2018 Mar;98(3):742-746. doi: 10.4269/ajtmh.17-0735. Epub 2018 Feb 1.

18.

Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America - Map Gallery.

Mourão PHO, Gavalda J, Salvador F, Molina I.

Transplantation. 2018 Feb;102(2S Suppl 2):S81. doi: 10.1097/TP.0000000000002031. Review. No abstract available.

PMID:
29381582
19.

Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study.

Fernández-Hidalgo N, Ribera A, Larrosa MN, Viedma E, Origüen J, de Alarcón A, Fariñas MC, Sáez C, Peña C, Múñez E, García López MV, Gavaldà J, Pérez-Montarelo D, Chaves F, Almirante B.

Clin Microbiol Infect. 2018 Sep;24(9):985-991. doi: 10.1016/j.cmi.2017.12.002. Epub 2017 Dec 18.

20.

High-Dose Daptomycin Is Effective as an Antibiotic Lock Therapy in a Rabbit Model of Staphylococcus epidermidis Catheter-Related Infection.

Basas J, Palau M, Ratia C, Del Pozo JL, Martín-Gómez MT, Gomis X, Torrents E, Almirante B, Gavaldà J.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01777-17. doi: 10.1128/AAC.01777-17. Print 2018 Feb.

21.

A single point mutation in class III ribonucleotide reductase promoter renders Pseudomonas aeruginosa PAO1 inefficient for anaerobic growth and infection.

Crespo A, Gavaldà J, Julián E, Torrents E.

Sci Rep. 2017 Oct 17;7(1):13350. doi: 10.1038/s41598-017-14051-2.

22.

Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andujar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual A, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J; Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016).

Transplant Rev (Orlando). 2018 Jan;32(1):36-57. doi: 10.1016/j.trre.2017.07.001. Epub 2017 Jul 26. Review.

PMID:
28811074
23.

Case Report: Successful Lung Transplantation from a Donor Seropositive for Trypanosoma cruzi Infection (Chagas Disease) to a Seronegative Recipient.

Salvador F, Sánchez-Montalvá A, Sulleiro E, Berastegui C, Jauregui A, Pont T, Los-Arcos I, Len Ó, Gavaldà J, Molina I.

Am J Trop Med Hyg. 2017 Oct;97(4):1147-1150. doi: 10.4269/ajtmh.17-0156. Epub 2017 Jul 27.

24.

Successful liver transplantation despite donor-transmitted ESBL-producing Klebsiella pneumoniae infection: Case report and review of the literature.

Escolà-Vergé L, Los-Arcos I, José González-López J, Lung M, Bilbao I, Farré M, Pont T, Sandiumenge A, Gavaldà J, Len O.

Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12743. Epub 2017 Aug 2. Review.

PMID:
28691772
25.

Pathogenic Characteristics of Staphylococcus aureus Endovascular Infection Isolates from Different Clonal Complexes.

Pérez-Montarelo D, Viedma E, Murcia M, Muñoz-Gallego I, Larrosa N, Brañas P, Fernández-Hidalgo N, Gavaldà J, Almirante B, Chaves F.

Front Microbiol. 2017 May 19;8:917. doi: 10.3389/fmicb.2017.00917. eCollection 2017.

26.

Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial.

Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavaldà J, Moreno A, Torre-Cisneros J, Montejo JM, Fortun J, Muñoz P, Sabé N, Fariñas MC, Blanes-Julia M, López-Medrano F, Suárez-Benjumea A, Martinez-Atienza J, Rosso-Fernández C, Pérez-Romero P; TRANSGRIPE 1–2 Study Group.

Clin Infect Dis. 2017 Apr 1;64(7):829-838. doi: 10.1093/cid/ciw855.

PMID:
28362949
27.

Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.

Monforte V, Sintes H, López-Gallo C, Delgado M, Santos F, Zurbano F, Solé A, Gavaldá J, Borro JM, Redel-Montero J, Cifrian JM, Pastor A, Román A, Ussetti P.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12694. Epub 2017 May 9.

PMID:
28294487
28.

Blood and tissue distribution of posaconazole in a rat model of invasive pulmonary aspergillosis.

Cendejas-Bueno E, Forastiero A, Ruiz I, Mellado E, Gavaldà J, Gomez-Lopez A.

Diagn Microbiol Infect Dis. 2017 Feb;87(2):112-117. doi: 10.1016/j.diagmicrobio.2016.10.010. Epub 2016 Oct 11.

PMID:
27889253
29.

Galactomannan enzyme immunoassay and quantitative Real Time PCR as tools to evaluate the exposure and response in a rat model of aspergillosis after posaconazole prophylaxis.

Cendejas-Bueno E, Forastiero A, Ruiz I, Mellado E, Buitrago MJ, Gavaldà J, Gomez-Lopez A.

Enferm Infecc Microbiol Clin. 2016 Nov;34(9):571-576. doi: 10.1016/j.eimc.2015.11.008. Epub 2016 Jan 21.

PMID:
26804792
30.

Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study.

Peghin M, Hirsch HH, Len Ó, Codina G, Berastegui C, Sáez B, Solé J, Cabral E, Solé A, Zurbano F, López-Medrano F, Román A, Gavaldá J.

Am J Transplant. 2017 May;17(5):1304-1312. doi: 10.1111/ajt.14042. Epub 2016 Oct 14.

31.

Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique.

Basas J, Morer A, Ratia C, Martín MT, Del Pozo JL, Gomis X, Rojo-Molinero E, Torrents E, Almirante B, Gavaldà J.

J Antimicrob Chemother. 2016 Oct;71(10):2895-901. doi: 10.1093/jac/dkw251. Epub 2016 Jul 4.

PMID:
27378814
32.

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisán S, Carratalá J, Cervera C, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Frauca E, Gavaldá J, Hernández D, Herrero I, Len O, Lopez-Medrano F, Manito N, Marcos MA, Martín-Dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pérez-Romero P, Rodriguez-Bernot A, Rumbao J, San Juan R, Vaquero JM, Vidal E; Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI).

Transplant Rev (Orlando). 2016 Jul;30(3):119-43. doi: 10.1016/j.trre.2016.04.001. Epub 2016 Apr 29. Review.

PMID:
27132815
33.

Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.

Fortún J, Muriel A, Martín-Dávila P, Montejo M, Len O, Torre-Cisneros J, Carratalá J, Muñoz P, Fariñas C, Moreno A, Fresco G, Goikoetxea J, Gavaldá J, Pozo JC, Bodro M, Vena A, Casafont F, Cervera C, Silva JT, Aguado JM; Grupo de Estudio de Infección en Pacientes Trasplantados-Grupo de Estudio de Micología Médica (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica), and Red Española de Investigación en Patología Infecciosa.

Liver Transpl. 2016 Apr;22(4):427-35. doi: 10.1002/lt.24391.

34.

Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients.

Peghin M, Monforte V, Martin-Gomez MT, Ruiz-Camps I, Berastegui C, Saez B, Riera J, Solé J, Gavaldá J, Roman A.

Transpl Infect Dis. 2016 Feb;18(1):70-8. doi: 10.1111/tid.12492. Epub 2016 Feb 3.

PMID:
26678668
35.

10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.

Peghin M, Monforte V, Martin-Gomez MT, Ruiz-Camps I, Berastegui C, Saez B, Riera J, Ussetti P, Solé J, Gavaldá J, Roman A.

Transpl Int. 2016 Jan;29(1):51-62. doi: 10.1111/tri.12679. Epub 2015 Oct 12.

36.

Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe.

Pérez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavaldá J, Aydillo TA, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, Blanes M, Fortún J, Suárez-Benjumea A, López-Medrano F, Barranco JL, Peghin M, Roca C, Lara R, Cordero E; Influenza Vaccine in Solid Organ Transplant Recipient Study Group, Spanish Network of Research in Infectious Diseases (REIPI-GESITRA); Influenza Vaccine in Solid Organ Transplant Recipient Study Group Spanish Network of Research in Infectious Diseases REIPI-GESITRA.

Clin Microbiol Infect. 2015 Nov;21(11):1040.e11-8. doi: 10.1016/j.cmi.2015.07.014. Epub 2015 Jul 29.

37.

Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.

Baelo A, Levato R, Julián E, Crespo A, Astola J, Gavaldà J, Engel E, Mateos-Timoneda MA, Torrents E.

J Control Release. 2015 Jul 10;209:150-8. doi: 10.1016/j.jconrel.2015.04.028. Epub 2015 Apr 23.

PMID:
25913364
38.

Methyl-hydroxylamine as an efficacious antibacterial agent that targets the ribonucleotide reductase enzyme.

Julián E, Baelo A, Gavaldà J, Torrents E.

PLoS One. 2015 Mar 17;10(3):e0122049. doi: 10.1371/journal.pone.0122049. eCollection 2015.

39.

Ventilator-associated respiratory infection following lung transplantation.

Riera J, Caralt B, López I, Augustin S, Roman A, Gavalda J, Rello J; Vall d’Hebron Lung Transplant Study Group.

Eur Respir J. 2015 Mar;45(3):726-37. doi: 10.1183/09031936.00095214. Epub 2014 Oct 30.

40.

Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial.

Martinez-Atienza J, Rosso-Fernández C, Roca C, Aydillo TA, Gavaldà J, Moreno A, Montejo JM, Torre-Cisneros J, Fariñas MC, Fortun J, Sabé N, Muñoz P, Blanes-Julia M, Suárez-Benjumea A, López-Medrano F, Pérez-Romero P, Cordero E; TRANSGRIPE 1-2 Study Group.

Trials. 2014 Aug 28;15:338. doi: 10.1186/1745-6215-15-338.

41.

Multidrug-resistant bacteria in solid organ transplant recipients.

Cervera C, van Delden C, Gavaldà J, Welte T, Akova M, Carratalà J; ESCMID Study Group for Infections in Compromised Hosts.

Clin Microbiol Infect. 2014 Sep;20 Suppl 7:49-73. doi: 10.1111/1469-0691.12687. Review.

42.

Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors.

Peghin M, Ruiz-Camps I, Garcia-Vidal C, Cervera C, Andreu J, Martin M, Gavaldá J, Gudiol C, Moreno A, Felip E, Pahissa A.

J Infect. 2014 Oct;69(4):387-95. doi: 10.1016/j.jinf.2014.03.018. Epub 2014 May 15.

PMID:
24844823
43.

Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation.

Len O, Montejo M, Cervera C, Fariñas MC, Sabé N, Ramos A, Cordero E, Torre-Cisneros J, Martín-Dávila P, Azanza JR, Pahissa A, Gavaldà J; DAPTOSOT (Daptomycin in Solid Organ Transplantation) Study Group.

Transpl Infect Dis. 2014 Aug;16(4):532-8. doi: 10.1111/tid.12232. Epub 2014 May 19.

PMID:
24834833
44.

Invasive fungal infections in solid organ transplant recipients.

Gavaldà J, Meije Y, Fortún J, Roilides E, Saliba F, Lortholary O, Muñoz P, Grossi P, Cuenca-Estrella M; ESCMID Study Group for Infections in Compromised Hosts.

Clin Microbiol Infect. 2014 Sep;20 Suppl 7:27-48. doi: 10.1111/1469-0691.12660. Review.

45.

A special issue on infections in solid organ transplant recipients.

Gavaldà J, Aguado JM, Manuel O, Grossi P, Hirsch HH; ESCMID Study Group of Infection in Compromised Hosts.

Clin Microbiol Infect. 2014 Sep;20 Suppl 7:1-3. doi: 10.1111/1469-0691.12658. No abstract available.

46.

Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.

Meije Y, Fortún J, Len Ó, Aguado JM, Moreno A, Cisneros JM, Gurguí M, Carratalà J, Muñoz P, Montejo M, Blanes M, Bou G, Pérez JL, Torre-Cisneros J, Ramos A, Pahissa A, Gavaldà J; Spanish Network for Research on Infection in Transplantation (RESITRA) and the Spanish Network for Research on Infectious Diseases (REIPI).

Transpl Infect Dis. 2014 Jun;16(3):387-96. doi: 10.1111/tid.12226. Epub 2014 May 8.

PMID:
24807640
47.

Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study.

Pérez-Cameo C, Vargas V, Castells L, Bilbao I, Campos-Varela I, Gavaldà J, Pahissa A, Len O.

Liver Transpl. 2014 Jul;20(7):856-63. doi: 10.1002/lt.23889. Epub 2014 May 26.

48.

Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.

Meije Y, Almirante B, Del Pozo JL, Martín MT, Fernández-Hidalgo N, Shan A, Basas J, Pahissa A, Gavaldà J.

J Infect. 2014 Jun;68(6):548-52. doi: 10.1016/j.jinf.2014.01.001. Epub 2014 Jan 8.

PMID:
24412247
49.

Liver biopsy-related infection in liver transplant recipients: A current matter of concern?

Sánchez CL, Len O, Gavalda J, Bilbao I, Castells L, Gelabert MA, Allende H, Pahissa A.

Liver Transpl. 2014 May;20(5):552-6. doi: 10.1002/lt.23817. Epub 2014 Jan 27.

50.

[Lung transplantation in pulmonary fibrosis and other interstitial lung diseases].

Berastegui C, Monforte V, Bravo C, Sole J, Gavalda J, Tenório L, Villar A, Rochera MI, Canela M, Morell F, Roman A.

Med Clin (Barc). 2014 Sep 15;143(6):239-44. doi: 10.1016/j.medcli.2013.06.026. Epub 2013 Sep 9. Spanish.

PMID:
24029451

Supplemental Content

Loading ...
Support Center